Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nView Health is a U.S. digital behavioral health company that rebranded in December 2022 as Proem Behavioral Health. The company provides software and digitally delivered mental health assessment tools used by healthcare providers, behavioral health clinics, substance use disorder programs, and clinical researchers to screen, diagnose, monitor, and measure outcomes for mental illness. Its offerings center on evidence-based, licensed behavioral health instruments, including the digital M.I.N.I., and workflow tools intended to support measurement-based care and clinical trial participant selection. The business is not a drug developer; instead, it operates as a commercial health technology company focused on behavioral health assessment, triage, and outcomes tracking. The company appears to remain privately held and headquartered in Atlanta, Georgia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on nView Health.